• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5075015)   Today's Articles (211)
For: Chu D, Popovic M, Chow E, Cella D, Beaumont JL, Lam H, Nguyen J, Giovanni JD, Pulenzas N, Bedard G, Bottomley A. Development, characteristics and validity of the EORTC QLQ-PR25 and the FACT-P for assessment of quality of life in prostate cancer patients. J Comp Eff Res 2014;3:523-31. [DOI: 10.2217/cer.14.41] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]  Open
Number Cited by Other Article(s)
1
Kempin S, Buchner A, Brose SF, Schmidt-Hegemann N, May M, Wolff I, Kravchuk A, Stief C, Brookman-May SD, Enzinger B. The Effect of Resistance and/or Aerobic Training on Quality of Life, Fitness, and Body Composition in Prostate Cancer Patients-A Systematic Review and Meta-Analysis. Cancers (Basel) 2024;16:4286. [PMID: 39766184 PMCID: PMC11674139 DOI: 10.3390/cancers16244286] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2024] [Revised: 12/16/2024] [Accepted: 12/20/2024] [Indexed: 01/11/2025]  Open
2
Padden-Modi M, Rush H, Abdel-Aty H, Matheson D, Millman R, Williams P, Tombal B, James N. How Can Participant Experience of Quality-of-Life Research Be Improved in Cancer Research: Views of the Patient and Public Involvement Representatives from the STAMPEDE2 Prostate Cancer Trial. Eur Urol Oncol 2024;7:990-992. [PMID: 39168780 DOI: 10.1016/j.euo.2024.07.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2024] [Revised: 07/10/2024] [Accepted: 07/31/2024] [Indexed: 08/23/2024]
3
Mittal C, Gupta H, Nagpal C, Sahoo RK, Sharma A, Gangadharaiah BB, Tansir G, Panaiyadiyan S, Shamim SA, Kaushal S, Das CJ, Haresh KP, Seth A, Nayak B, Batra A. Quality of Life Determinants in Patients with Metastatic Prostate Cancer: Insights from a Cross-Sectional Questionnaire-Based Study. Curr Oncol 2024;31:4940-4954. [PMID: 39329994 PMCID: PMC11430678 DOI: 10.3390/curroncol31090366] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2024] [Revised: 08/22/2024] [Accepted: 08/25/2024] [Indexed: 09/28/2024]  Open
4
Ross A, Brewer K, Hudgens S, Brown B, Fallick M, de Paauw-Holt S, Arondekar B, Clegg J, Hunsche E. Development of a Novel Patient-Reported Outcome Measure to Assess Symptoms and Impacts of Androgen Deprivation Therapy for Advanced Prostate Cancer. Adv Ther 2024;41:3076-3088. [PMID: 38861216 PMCID: PMC11263404 DOI: 10.1007/s12325-024-02888-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2024] [Accepted: 04/25/2024] [Indexed: 06/12/2024]
5
Calleja-Escudero J, Barrondo V, Rodriguez-Alonso A, Gómez-Veiga F, Bestard J, Gómez-Caamaño A, Grandoulier AS, Pérez-Sampietro M, Chantada-Abal V, Poza de Celis R. Evaluation of the criteria for renewal of LHRH agonists in patients with prostate cancer: results of the ANAREN Study. Drugs Context 2024;13:2024-2-2. [PMID: 38915919 PMCID: PMC11195525 DOI: 10.7573/dic.2024-2-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2024] [Accepted: 04/30/2024] [Indexed: 06/26/2024]  Open
6
Ryding HG, Mitchell LJ, Rigby RR, Ball L, Hobby J, Williams LT. Effectiveness of dietetic care for cancer survivors in the primary care setting: A systematic review and meta-analysis of randomized controlled trials. J Cancer Surviv 2024:10.1007/s11764-024-01583-6. [PMID: 38710853 DOI: 10.1007/s11764-024-01583-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2024] [Accepted: 04/01/2024] [Indexed: 05/08/2024]
7
Gesztesi L, Kocsis ZS, Jorgo K, Fröhlich G, Polgár C, Ágoston P. Alterations of Sexual and Erectile Functions after Brachytherapy for Prostate Cancer Based on Patient-Reported Questionnaires. Prostate Cancer 2024;2024:5729185. [PMID: 38312318 PMCID: PMC10834089 DOI: 10.1155/2024/5729185] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2023] [Revised: 11/16/2023] [Accepted: 01/08/2024] [Indexed: 02/06/2024]  Open
8
Zamora V, Garin O, Suárez JF, Jové J, Castells M, Ferrer F, Gutiérrez C, Guedea F, Boladeras A, Fumadó L, Roselló A, Pastor J, Samper P, Pont À, Ferrer M. Psychometric validation of the Spanish version of the Expanded Prostate Cancer Index Composite-26. World J Urol 2023;41:3511-3518. [PMID: 37947846 PMCID: PMC10693511 DOI: 10.1007/s00345-023-04691-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2023] [Accepted: 10/10/2023] [Indexed: 11/12/2023]  Open
9
Expanding access to rectal spacers in the United Kingdom: an examination of current evidence and an early review of data from a single institution. JOURNAL OF RADIOTHERAPY IN PRACTICE 2022. [DOI: 10.1017/s146039692200022x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
10
Galvão DA, Taaffe DR, Hayne D, Lopez P, Lyons-Wall P, Tang CI, Chambers SK, Devine A, Spry N, Jeffery E, Kudiarasu C, Joseph D, Newton RU. Weight loss for overweight and obese patients with prostate cancer: a study protocol of a randomised trial comparing clinic-based versus Telehealth delivered EXercise and nutrition intervention (the TelEX trial). BMJ Open 2022;12:e058899. [PMID: 35667725 PMCID: PMC9171278 DOI: 10.1136/bmjopen-2021-058899] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
11
Ratti MM, Gandaglia G, Alleva E, Leardini L, Sisca ES, Derevianko A, Furnari F, Mazzoleni Ferracini S, Beyer K, Moss C, Pellegrino F, Sorce G, Barletta F, Scuderi S, Omar MI, MacLennan S, Williamson PR, Zong J, MacLennan SJ, Mottet N, Cornford P, Aiyegbusi OL, Van Hemelrijck M, N'Dow J, Briganti A. Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review. Eur Urol Oncol 2021;5:153-163. [PMID: 34785188 DOI: 10.1016/j.euo.2021.10.004] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2021] [Revised: 09/30/2021] [Accepted: 10/15/2021] [Indexed: 01/27/2023]
12
Galvão DA, Taaffe DR, Chambers SK, Fairman CM, Spry N, Joseph D, Newton RU. Exercise intervention and sexual function in advanced prostate cancer: a randomised controlled trial. BMJ Support Palliat Care 2020;12:29-32. [PMID: 33328218 PMCID: PMC8862060 DOI: 10.1136/bmjspcare-2020-002706] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2020] [Revised: 11/24/2020] [Accepted: 11/30/2020] [Indexed: 12/30/2022]
13
Marandino L, De Luca E, Zichi C, Lombardi P, Reale ML, Pignataro D, Di Stefano RF, Ghisoni E, Mariniello A, Trevisi E, Leone G, Muratori L, La Salvia A, Sonetto C, Buttigliero C, Tucci M, Aglietta M, Novello S, Scagliotti GV, Perrone F, Di Maio M. Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018. Clin Genitourin Cancer 2019;17:332-347.e2. [PMID: 31416754 DOI: 10.1016/j.clgc.2019.07.007] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2019] [Revised: 07/06/2019] [Accepted: 07/15/2019] [Indexed: 01/20/2023]
14
Adlard KN, Jenkins DG, Salisbury CE, Bolam KA, Gomersall SR, Aitken JF, Chambers SK, Dunn JC, Courneya KS, Skinner TL. Peer support for the maintenance of physical activity and health in cancer survivors: the PEER trial - a study protocol of a randomised controlled trial. BMC Cancer 2019;19:656. [PMID: 31269917 PMCID: PMC6610872 DOI: 10.1186/s12885-019-5853-4] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2019] [Accepted: 06/19/2019] [Indexed: 12/20/2022]  Open
15
Weekly versus 3-weekly cabazitaxel for the treatment of castration-resistant prostate cancer: A randomised phase II trial (ConCab). Eur J Cancer 2018;97:33-40. [DOI: 10.1016/j.ejca.2018.03.007] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2017] [Revised: 03/05/2018] [Accepted: 03/09/2018] [Indexed: 12/30/2022]
16
Kutwin P, Konecki T, Jabłonowski Z, Wolski Z, Sosnowski M. Quality of life in a population of Polish patients with prostate cancer. Cent European J Urol 2016;69:53-6. [PMID: 27123327 PMCID: PMC4846715 DOI: 10.5173/ceju.2016.633] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2015] [Revised: 07/06/2015] [Accepted: 08/28/2015] [Indexed: 11/26/2022]  Open
17
Kim W, Ryan CJ. Use of androgen receptor signaling-targeted therapies in chemotherapy-naive metastatic castration-resistant prostate cancer: a call for patient-centered studies. J Comp Eff Res 2015;5:5-7. [PMID: 26690748 DOI: 10.2217/cer.15.61] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA